132539-06-1
Chemical Structure
Olanzapine
Synonym(s): LY170053
- CAS No.: 132539-06-1
- Formula:C17H20N4S
- Molecular Weight:312.44
IUPAC Name: 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine
InChIKey: KVWDHTXUZHCGIO-UHFFFAOYSA-N
SMILES: CC1=CC(C(N2CCN(C)CC2)=N3)=C(S1)NC4=C3C=CC=C4
Biological Activity: Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Olanzapine | 99.96% | Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine (Standard) | 99.98% | Olanzapine (Standard) is the analytical standard of Olanzapine. This product is intended for research and analytical applications. Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d4 | Olanzapine-d4 (LY170053-d4) is deuterium-labeled Olanzapine (HY-14541). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d8 | Olanzapine-d8 is a deuterated labeled Olanzapine. Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d3 | 98.57% | Olanzapine-d3 (LY170053-d3) is the deuterium labeled Olanzapine. Olanzapine is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptors (Ki=19 nM). Olanzapine is an atypical antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d15 | Olanzapine-d15 (LY170053-d15) is the deuterium labeled Olanzapine (HY-14541). Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki = 7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki = 11 to 31 nM), muscarinic M1-5 (Ki = 1.9-25 nM), and adrenergic α1 receptor (Ki = 19 nM). Olanzapine is an atypical antipsychotic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
